Four decades ago, a distinguished panel of clinicians and academicians gathered "to establish the syndrome of premenstrual tension (PMT) as a clinical entity and to point the way to a better understanding of its etiol ogy and treatment" (Morton 1953) . They were con cerned that "with an incidence of about 50% of all menstruating women, premenstrual tension must be regarded as the most common "nervous" disorder of women" and "the condition cannot be dismissed as be ing neurotic or primarily psychogenic." The panelists concluded:
It is obvious that disagreement exists concerning the specifIc pathogenesis of PMT. It is also apparent that one or more of the symptoms may predominate in any one patient and for that reason, the etiologic pattern is not necessarily identical in every instance .... It would ap pear therefore that the problem of the etiology of PMT requires further investigation.
It is disheartening that 40 years after the panel and 60 years after Frank's (1931) pioneering reports on PMT, li terally dozens of papers include statements like "the etiology of Premenstrual syndrome (PMS) is still ob scure" and "agreed upon defInition and criteria are needed."
The report of the American College of Neuropsy-chopharmacology ACNP study group (Halbreich et al. 1993 ) is an attempt to delineate the points of consensus and disagreement in the fIeld, which we believe is the frrst step toward the development of broadly accepted operational criteria and interdisciplinary cooperation. The main issues raised by the four commentators (who did not participate in the study group) are as follows. 1) Is the delineation of a list of points really productive? 2) Is an alternative to the DSM-III-R and DSM-IV "premenstrual dysphoric disorder" entity necessary? 3) Is suppression of ovulation effective as a treatment for PMS; is surgical menopause justifIed for that pur pose? 4) What is the role of serotonin in the pathophys iology of PMS; what can we learn from the efficacy of serotonergic agonists as treatment for dysphoric PMS? 5) What are the roles of the environment and psychoso cial factors in the formation or expression of PMS? I strongly believe to achieve a substantial progress in this fIeld that an attempt at integration should be made. Di agnostic as well as treatment issues cannot be separated from pathophysiology. The pathophysiology is mul tidimensional and symptoms cannot be attributed to a single factor. Indeed, the environmental and psy chosocial aspects interact with the biological ones. Therefore, the points raised by the commentators will be addressed in an integrative solution-oriented way, instead of a point-to-point response that at least par tially would be repetitious of the study group report. During the last decade, a task force of the Ameri can Psychiatric Association (APA) has undertaken a commendable effort to examine PMS within the con text of the AP A's Diagnostic and Statistical Manual, 3rd edition revised (DSM-III-R, 1987) , to accommodate "an urgent need for diagnostic criteria to differentiate cases of PMS in which disturbance of mood predominates, from cases of PMS with only physical symptoms" (Spit zer et al. 1989 ). An attempt to achieve a consensus on operational criteria for this prevalent state (Davis 1985; Williams et al. 1983) Here a departure from the current phenomenology descriptive thinking will not only provide a common denominator but might also be conceptually more productive. The biological and diagnostic data support ing the following suggestions were reviewed by us in great detail (Halbreich et al. 1988) . To avoid redundancy and another lengthy review, only their relevant essence will be summarized here.
In the formulation of a framework for MRCs, some observations might be widely accepted and might serve as common denominators and a foundation for a fac tually based conceptualization. 1) The phenomenology of menstrually related changes is diversifi.ed and reflects involvement of many body systems including changes in mood and behavior, water retention, mastalgia, pain in various organs, migraine, changes in circulatory and autonomous systems, skin disorders, allergies and asthma, epilepsy, and numerous other changes (over 200 symptoms have been reported) (Halbreich et al. 1982; Dalton 1985) . 2) Many times clusters of symptoms (syndromes) can be identifi.ed, but sometimes a woman has only a single dominant symptom (e.g., asthma, temporal lobe epilepsy, a skin disorder) that appears cyclically and is usually entrained to the menstrual cy- 11) The cyclicity of symptoms is usually eliminated dur ing spontaneous anovulatory cycles (Backstrom et al. 1989), during pregnancy, and following menopause. 12) Cyclic PMS-like symptoms can be simulated in post menopausal women by treatment with sequential con traceptive pills (Hammerback et al. 1985) . 13) Symp toms were reported to appear with a time lag of 5 to 6 days after changes in levels of gonadal hormones (HaI breich et al. 1986; T. Backstrom, personal communica tion). 14) 
